Table 3 Clinical and pathological characteristics between different sites of initial presentation.

From: Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients

 

All

UTUC

BT

UTUC+BT

Chi-square or Z

p value

N (%)

45(100)

24(53.3)

11(24.4)

10(22.2)

  

Gender, no.(%)

    

0.433

0.805

 Male

15(33.3)

7(29.2)

4(36.5)

4(40.0)

  

 Female

30(66.7)

17(70.8)

7(63.6)

6(60.0)

  

Gross hematuria, no.(%)

    

2.253

0.324

 No

7(15.6)

2(8.3)

3(27.3)

2(20.0)

  

 Yes

38(84.4)

22(91.7)

8(72.7)

8(80.0)

  

Initial stage, no.(%)

    

7.745

0.101

 Ta-1

30(66.7)

15(62.5)

10(90.9)

5(50.0)

  

 T2

9(20.0)

5(20.8)

0(0)

4(40.0)

  

 T3

5(11.1)

4(16.7)

0(0)

1(10.0)

  

Initial grade, no.(%)

    

7.822

0.098

 G1

2(4.4)

0(0)

2(18.2)

0(0)

  

 G2

26(57.8)

15(62.5)

4(36.4)

7(70.0)

  

 G3

16(35.6)

9(37.5)

4(36.4)

3(30.0)

  

Interval to 2 nd site, means ± SD

 

26.93 ± 19.49

32.27 ± 25.11

 

−0.302

0.763

Interval to 3 rd site, means ± SD

 

44.07 ± 30.78

41.36 ± 40.09

23.00 ± 28.67

0.478

0.788

Local recurrence, no.(%)

    

5.893

0.053

 No

26(57.8)

17(70.8)

3(27.3)

6(60.0)

  

 Yes

19(42.2)

7(29.2)

8(72.7)

4(40.0)

  

Highest stage, no.(%)

    

2.003

0.735

 T1

18(40.0)

10(41.7)

3(27.3)

5(50.0)

  

 T2

17(37.8)

8(33.3)

6(54.5)

3(30.0)

  

 T3

10(22.2)

6(25.0)

2(18.2)

2(20.0)

  

Highest grade, no.(%)

    

3.852

0.146

 G2

22(48.9)

12(50.0)

3(27.3)

7(70.0)

  

 G3

23(51.1)

12(50.0)

8(72.7)

3(30.0)

  

Multifocality, no.(%)

    

0.218

0.897

 No

10(22.2)

5(20.8)

3(27.3)

2(20.0)

  

 Yes

35(77.8)

19(79.2)

8(72.7)

8(80.0)

  

Architecture, no.(%)

    

0.755

0.686

 Papillary

37(82.2)

19(79.2)

10(90.9)

8(80.0)

  

 Sessile

8(17.8)

5(20.8)

1(9.1)

2(20.0)

  

Tumor size, means ± SD

 

2.77 ± 1.85

2.33 ± 0.89

2.79 ± 1.62

0.024

0.988

  1. UTUC = upper tract urothelial carcinoma; BT = bladder tumor; SD = standard deviation.